Dublin, Ireland – ERS Genomics Limited and Lonza Pharma & Biotech announced today a license agreement to provide Lonza with access to ERS Genomics’ CRISPR/Cas9 genome editing technology patents. Lonza will have the ability to utilize CRISPR/Cas9 in its bioproduction products and services and also for use in induced pluripotent stem cells (iPSC) for research applications. […]
Largest-ever Protein Measurement Study Enhances deCODE’s Efforts in Basic Research, Drug Discovery and Novel Protein-based Diagnostics deCODE genetics, an Amgen subsidiary, and SomaLogic, Inc. today announced a collaboration that brings together SomaLogic’s expertise in human proteins with deCODE’s expertise in human genetics. The collaboration combines deCODE’s rich data sets with SomaLogic’s leading protein measurement capabilities […]
The reduction of SOx emissions currently is a pressing topic for the maritime industry. Effective from 1 January 2020, the global sulfur cap will be reduced from 3.50% to 0.50% under the revised MARPOL Annex VI regulation. One important strategy for ship owners to comply with this requirement is the installation of exhaust gas scrubbers. […]
– Potsdam – Oculyze, the world’s premier platform for mobile image analysis and BIOTECON Diagnostics, a renowned food and beverage quality testing provider today announced the signing of a strategic partnership. The agreement signed at the corporate offices of BIOTECON Diagnostics in Potsdam, appoints the Company as the exclusive global distributor of Oculyze’s latest technological […]
OnRamp’s ROSALIND and Active Motif offer an improved ChIP-Seq data analysis experience for researchers with state-of-the-art dynamics track plots and advanced collaboration capabilities SAN DIEGO — OnRamp BioInformatics, a genomics company focused on scientist-friendly bioinformatics software solutions, today announced they are working with Active Motif to improve accuracies in data analysis for ChIP-Seq experiments. OnRamp’s flagship […]
Berkeley Lights, Inc. and Novo Nordisk today announced that Novo Nordisk has purchased the Beacon®Optofluidic platform to accelerate workflows in cell line development and to use the platform for future protein and antibody discovery. “We are committed to raising the height of our innovation by adopting new technologies that make drug discovery and development more […]
Clustermarket, the leading UK online scientific equipment sharing and booking platform, has enlisted the support of GE Healthcare’s Life Sciences business in an agreement aimed at helping innovators in the UK access specialized life sciences and biotech equipment. LONDON Clustermarket’s platform will allow owners of GE Healthcare Life Sciences instruments to hire out and maximize […]
BC Platforms AG, a world leader in genomic data management and analytics, today announces that it has partnered with Medaffcon Oy, a company specialized in generating Real World Evidence for health-related decision-making. Medaffcon provides medical, scientific and market access services to international pharmaceutical and biotechnology industries as well as health care operators. The partnership focuses […]
Partnership merges Schrödinger’s advanced modeling capabilities with TB Alliance’s expertise in tuberculosis biology to accelerate the development of next-generation treatments NEW YORK – Dec. 11, 2018 – Schrödinger and TB Alliance today announced a three-year research collaboration to speed the development of next-generation tuberculosis (TB) treatments by leveraging Schrödinger’s advanced computational platform for drug discovery. The […]
Making protein analysis easier and quicker The partnership announced today between Qlucore and Cambridge Protein Arrays Ltd (CPA) will strengthen the end-to-end solution for protein analysis. Users will benefit from a broad and extensive protein analysis and immediate access to results visualization and analysis. An experiment performed using CPA’s arrays can be followed by data […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
